Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Sinor Biotechnology is a specialized biotechnology company based in Nanjing, China, focusing on the research, development, and production of peptide-related products. The company provides a wide range of amino acid derivatives, peptide reagents, and custom peptide synthesis services to the global pharmaceutical and life sciences industries. Their expertise includes the large-scale production of high-quality biochemicals used in drug discovery and development. Sinor Biotechnology operates modern manufacturing facilities and maintains rigorous quality control standards to support its international clientele. The company serves as a key supplier for researchers and manufacturers working on peptide-based therapeutics and diagnostic tools. Their product catalog includes specialized coupling reagents and protected amino acids essential for modern medicinal chemistry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Sinor Biotechnology.